Biopharmaceutical company Aimmune Therapeutics says the US Food and Drug Administration has approved its drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17 and that it had priced it at $US890 ($A1,330) per month.
from Breaking News | Daily Telegraph https://ift.tt/2S3JX5k
from Breaking News | Daily Telegraph https://ift.tt/2S3JX5k
Comments
Post a Comment